Xacc/280 Week 7 Randomization

During the final week of inpatient stay, subjects received BNX counselling and were given their emergency cards. Additionally, subjects were evaluated for the inclusion in an outpatient 16-weeks psychosocial program “Matrix” by the psychologists offered the program. Following allocation to treatment condition, appointments for the first week were made to the TDM and TAU subjects who were not discharged over the weekend as this practice was identified to be a high risk situation for relapse. 11.7 Randomisation procedure Participants were allocated to the experimental or control conditions on a 1:1 basis. The randomization procedure is implemented in the NRC’s inpatient setting just prior to discharge from the outpatient programme. An online

If patient did not attend the clinic or if the UDS is positive for drug use, patients continue on DOT. Those who provide a negative drug test at their last visit in the first week, are given a one-week take home prescription. If the provided UDS is positive, then patient should continue on DOT for another week. However, if the UDS provided is negative, then the patients’ take home dose extends by one week each visit until a maximum time of 4 weeks take home doses. The patient is advised not to take the BNX-F dose on the follow-up visit and will be further advised that the quantity dispensed for scheduled visits will account for that. The predicted concentration for this sample are contrasted with assay results. Non-adherent or non-abstinent patients will be pushed down one level on their take home doses. For example, if the patient is on three week take-home doses and was found non-compliant, as per the TDM results, or provided a random positive UDS, he is therefore, brought down to two weeks take-home doses and in same connection from two weeks to one week and then DoT instead of extending take-home doses to four